Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-20Immune System, Inflammation, Migraine - The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology
-
CLINICAL_TRIALS study record update · 2025-11-20Usability of the MeTime MS Acupressure Mobile Application in Adults With MS
-
CLINICAL_TRIALS study record update · 2025-11-19Assessment of Perceptive Accuracy for Motor Performance in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-11-18Mechanical Determinants of Upper Limbs Oscillation During Gait
-
CLINICAL_TRIALS study record update · 2025-11-14Identifying and Characterizing Preclinical MS
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-13NARCOMS Global Multiple Sclerosis Registry: A Long-Term Study to Facilitate Research in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-11-12A Single Arm, Open Label Multicentre Extension Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Multiple Sclerosis Previously Enrolled In A F. Hoffmann-La Roche Sponsored Ocrelizumab Phase IIIb/IV Clinical Trials
-
CLINICAL_TRIALS study record update · 2025-11-10Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
-
CLINICAL_TRIALS study record update · 2025-10-31RESET-MS: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-10-31"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
-
CLINICAL_TRIALS study record update · 2025-10-30Effects of a Single Bout of Moderate Intensity Aerobic Cycling Exercise Combined With Virtual Reality on Processing Speed in Persons With Multiple Sclerosis and Mobility Disability
-
CLINICAL_TRIALS study record update · 2025-10-30CARE in MS: Childhood Adversity Research Effort in MS
-
CLINICAL_TRIALS study record update · 2025-10-29ImmuneNet: Quantum-Synaptic Immunotherapy Mapping
-
CLINICAL_TRIALS study record update · 2025-10-29HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS) - Efficacy Trial
-
CLINICAL_TRIALS study record update · 2025-10-29MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-10-28A Pilot Study of the Pharmacodynamics and Clinical Effects of Oral Extended Release (OER) Glibenclamide in Multiple Sclerosis Patients With Neuropathic Pain
-
CLINICAL_TRIALS study record update · 2025-10-27Effects of Antiviral Therapies on Epstein-Barr Virus Replication
-
CLINICAL_TRIALS study record update · 2025-10-20A Pilot Randomized Controlled Trial of A Comprehensive Cognitive and Affective Intervention for Neurocognitive Disorders (CoINTEGRATE)
-
CLINICAL_TRIALS study record update · 2025-10-20Effect of Alemtuzumab on Microglial Activation Assessed Using Novel [F-18]-Based Positron Emission Tomography (PET) Ligand in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-10-20Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
-
CLINICAL_TRIALS study record update · 2025-10-16An Observational Study Utilising Data From Big MS Data Registries to Evaluate the Long-Term Safety of Vumerity and Tecfidera
-
CLINICAL_TRIALS study record update · 2025-10-15Care Technology to Ascertain, Treat, and Engage the Community to Heal Depression in Patients With Multiple Sclerosis: Closing the Gaps in Depression Care for People With MS By Closing the Information Loop
-
CLINICAL_TRIALS study record update · 2025-10-15A Phase 2 Double-blind, Randomized, Placebo-controlled Study Evaluating the Effect of SAR443820 on Serum Neurofilament Levels in Participants With Multiple Sclerosis, Followed by an Open-label Long-term Extension Period
-
CLINICAL_TRIALS study record update · 2025-10-14Randomized Controlled Trial of MIND Diet for Neuroprotection and Symptom Management in MS
-
CLINICAL_TRIALS study record update · 2025-10-09Comparing Telehealth-Delivered Cognitive Behavioral Therapy for Insomnia to Web-Based to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection